Literature DB >> 9333172

Polymerase chain reaction detection and clinical significance of varicella-zoster virus in cerebrospinal fluid from human immunodeficiency virus-infected patients.

D G Burke1, R C Kalayjian, V R Vann, S A Madreperla, H E Shick, D G Leonard.   

Abstract

Varicella-zoster virus (VZV) causes ocular and other central nervous system (CNS) disease in human immunodeficiency virus (HIV)-infected persons. To study the prevalence of CNS disease due to VZV, cerebrospinal fluid (CSF) specimens from 84 consecutive HIV-infected patients with new neurologic symptoms were tested for VZV DNA by a polymerase chain reaction (PCR) assay. Six patients were PCR-positive for VZV in CSF; 3 additional patients were subsequently identified who were not part of the serial population sample. Among these 9 patients, all had clinical presentations consistent with ocular and other CNS disease due to VZV; 4 were without zoster on presentation. Sustained improvement in association with antiviral therapy was observed in 3. Therefore, VZV DNA was detected in the CSF of 7% of HIV-infected patients presenting with neurologic symptoms; the diagnosis of VZV-related CNS disease was facilitated by this assay; improvement in association with antiviral therapy was observed in some patients.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9333172     DOI: 10.1086/516516

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  10 in total

1.  LightCycler multiplex PCR for the laboratory diagnosis of common viral infections of the central nervous system.

Authors:  S J Read; J L Mitchell; C G Fink
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

2.  Herpesvirus infection of eye and brain in HIV infected patients.

Authors:  R F Miller; M R Howard; P Frith; C J Perrons; I Pecorella; S B Lucas
Journal:  Sex Transm Infect       Date:  2000-08       Impact factor: 3.519

Review 3.  Central nervous system infection during immunosuppression.

Authors:  Joseph R Zunt
Journal:  Neurol Clin       Date:  2002-02       Impact factor: 3.806

4.  Laboratory diagnosis of common viral infections of the central nervous system by using a single multiplex PCR screening assay.

Authors:  S J Read; J B Kurtz
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

5.  Subclinical reactivation of varicella zoster virus in all stages of HIV infection.

Authors:  Marius Birlea; Gabriele Arendt; Eser Orhan; D Scott Schmid; William J Bellini; Christian Schmidt; Don Gilden; Randall J Cohrs
Journal:  J Neurol Sci       Date:  2011-03-17       Impact factor: 3.181

6.  Diagnostic utility of a multiplex herpesvirus PCR assay performed with cerebrospinal fluid from human immunodeficiency virus-infected patients with neurological disorders.

Authors:  C Quereda; I Corral; F Laguna; M E Valencia; A Tenorio; J E Echeverria; E Navas; P Martín-Dávila; A Moreno; V Moreno; J M Gonzalez-Lahoz; J R Arribas; A Guerrero
Journal:  J Clin Microbiol       Date:  2000-08       Impact factor: 5.948

7.  Neurological complications of varicella-zoster virus in human immunodeficiency virus-infected patients: changes in prevalence and diagnostic utility of polymerase chain reaction in cerebrospinal fluid.

Authors:  Iñigo Corral; Carmen Quereda; Antonio Antela; Vicente Pintado; José Luis Casado; Pilar Martín-Dávila; Enrique Navas; Santiago Moreno
Journal:  J Neurovirol       Date:  2003-02       Impact factor: 2.643

Review 8.  Determinants of neurological syndromes caused by varicella zoster virus (VZV).

Authors:  Peter Ge Kennedy; Trine H Mogensen
Journal:  J Neurovirol       Date:  2020-06-03       Impact factor: 2.643

Review 9.  Molecular analysis of cerebrospinal fluid in viral diseases of the central nervous system.

Authors:  Paola Cinque; Simona Bossolasco; Ake Lundkvist
Journal:  J Clin Virol       Date:  2003-01       Impact factor: 3.168

10.  Molecular Techniques in the Diagnosis of Central Nervous System Infections.

Authors:  Hong-Zhou Lu; Karen C. Bloch; Yi-Wei Tang
Journal:  Curr Infect Dis Rep       Date:  2002-08       Impact factor: 3.663

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.